In order for your asthma inhaler to work effectively, you'll need to care for it properly. If it isn't cleaned regularly and stored correctly, it can harbor debris or bacteria. That, in turn, can ...

HFA-based metered-dose inhalers (MDIs) contain a propellant to deliver the medication that will continue to spray even after the medication has run out. Therefore, when the medication is gone from the ...

Glenmark Pharma is a pharmaceutical company based out of India. This company deals with a number of segments in medical industry. Here is a look at the company's performance in recent years. Updated ...

Glenmark Pharmaceuticals shares will remain in focus on Thursday after the company acquired a 34% stake in O2 Renewable Energy XXIV Private Limited as part of its commitment to renewable energy ...

Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. The product pulls were reported in a recent edition of ...

A device costing just pennies, based on an idea by a University of Manchester Professor to help his son use an inhaler, could be a gamechanger for asthma patients. The impressive results are from ...

Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help ...

Analysts have ‘buy’ calls on Glenmark Pharmaceuticals Ltd., Hyundai Motor India Ltd., GE Vernova T&D India Ltd., Schneider Electric Infrastructure Ltd. and Prestige Estates Projects Ltd. The stock ...

Glenmark Pharmaceuticals share price: Pharmaceutical major Glenmark Pharmaceuticals shares rose up to 2.27 per cent to hit an intraday high of Rs 1,551.75 per share on Monday, December 16, 2024. The ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Lacosamide Oral Solution, 10 mg/mL. Glenmark's Lacosamide Oral Solution, 10 mg/mL is bioequivalent and therapeutically equivalent ...

Glenmark Pharma Pharmaceuticals Ltd on Monday, December 16, said its US unit has launched Lacosamide oral solution, 10mg/ml. It is an oral solution to treat seizures. The company said the solution is ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of lacosamide oral solution, 10 mg/mL. Glenmark’s lacosamide oral solution, 10 mg/mL is bioequivalent and therapeutically equivalent ...